-+ 0.00%
-+ 0.00%
-+ 0.00%

Rezolute Inc. Gains FDA Alignment on Streamlined Phase 3 Trial Design for Ersodetug in Tumor Hyperinsulinism

Reuters·09/02/2025 10:08:48

Please log in to view news